83 related articles for article (PubMed ID: 10632363)
1. Vaccine implications of folate binding protein, a novel cytotoxic T lymphocyte-recognized antigen system in epithelial cancers.
Peoples GE; Anderson BW; Lee TV; Murray JL; Kudelka AP; Wharton JT; Ioannides CG
Clin Cancer Res; 1999 Dec; 5(12):4214-23. PubMed ID: 10632363
[TBL] [Abstract][Full Text] [Related]
2. Generation of human tumor-specific CTLs in HLA-A2.1-transgenic mice using unfractionated peptides from eluates of human primary breast and ovarian tumors.
Gritzapis AD; Sotiriadou NN; Papamichail M; Baxevanis CN
Cancer Immunol Immunother; 2004 Nov; 53(11):1027-40. PubMed ID: 15164233
[TBL] [Abstract][Full Text] [Related]
3. Identification of a naturally processed HLA-A*02:01-restricted CTL epitope from the human tumor-associated antigen Nectin-4.
Lopez M; Ghidouche A; Rochas C; Godelaine D; Carrasco J; Colau D; Hames G; Montero-Julian FA; Coulie PG; Olive D
Cancer Immunol Immunother; 2016 Oct; 65(10):1177-88. PubMed ID: 27514672
[TBL] [Abstract][Full Text] [Related]
4. Ii-Key/HER-2/neu MHC class-II antigenic epitope vaccine peptide for breast cancer.
Gillogly ME; Kallinteris NL; Xu M; Gulfo JV; Humphreys RE; Murray JL
Cancer Immunol Immunother; 2004 Jun; 53(6):490-6. PubMed ID: 14740174
[TBL] [Abstract][Full Text] [Related]
5. Editing the immunopeptidome of melanoma cells using a potent inhibitor of endoplasmic reticulum aminopeptidase 1 (ERAP1).
Koumantou D; Barnea E; Martin-Esteban A; Maben Z; Papakyriakou A; Mpakali A; Kokkala P; Pratsinis H; Georgiadis D; Stern LJ; Admon A; Stratikos E
Cancer Immunol Immunother; 2019 Aug; 68(8):1245-1261. PubMed ID: 31222486
[TBL] [Abstract][Full Text] [Related]
6. Immunogenic HER-2/neu peptides as tumor vaccines.
Baxevanis CN; Sotiriadou NN; Gritzapis AD; Sotiropoulou PA; Perez SA; Cacoullos NT; Papamichail M
Cancer Immunol Immunother; 2006 Jan; 55(1):85-95. PubMed ID: 15948002
[TBL] [Abstract][Full Text] [Related]
7. The novel C24D synthetic polypeptide inhibits binding of placenta immunosuppressive ferritin to human T cells and elicits anti-breast cancer immunity in vitro and in vivo.
Solodeev I; Zahalka MA; Moroz C
Neoplasia; 2014 Sep; 16(9):741-50. PubMed ID: 25246274
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic T cells generated against heteroclitic peptides kill primary tumor cells independent of the binding affinity of the native tumor antigen peptide.
Zirlik KM; Zahrieh D; Neuberg D; Gribben JG
Blood; 2006 Dec; 108(12):3865-70. PubMed ID: 16902144
[TBL] [Abstract][Full Text] [Related]
9. In silico Evaluation of PLAC1-fliC As a Chimeric Vaccine against Breast Cancer.
Taheri-Anganeh M; Amiri A; Movahedpour A; Khatami SH; Ghasemi Y; Savardashtaki A; Mostafavi-Pour Z
Iran Biomed J; 2020 May; 24(3):173-82. PubMed ID: 31952435
[TBL] [Abstract][Full Text] [Related]
10. New T cell epitopes identified from an anti-idiotypic antibody mimicking ovarian cancer associated antigen.
Li W; Cui H; Meng FQ; Chang XH; Zhang G; Liu B; Li ZH
Cancer Immunol Immunother; 2008 Feb; 57(2):143-54. PubMed ID: 17618437
[TBL] [Abstract][Full Text] [Related]
11. Cancer testis antigen vaccination affords long-term protection in a murine model of ovarian cancer.
Chiriva-Internati M; Yu Y; Mirandola L; Jenkins MR; Chapman C; Cannon M; Cobos E; Kast WM
PLoS One; 2010 May; 5(5):e10471. PubMed ID: 20485677
[TBL] [Abstract][Full Text] [Related]
12. In Silico Design and Evaluation of PRAME+FliCΔD2D3 as a New Breast Cancer Vaccine Candidate.
Taheri-Anganeh M; Savardashtaki A; Vafadar A; Movahedpour A; Shabaninejad Z; Maleksabet A; Amiri A; Ghasemi Y; Irajie C
Iran J Med Sci; 2021 Jan; 46(1):52-60. PubMed ID: 33487792
[TBL] [Abstract][Full Text] [Related]
13. Targeted acidosis mediated delivery of antigenic MHC-binding peptides.
Kelly JJ; Ankrom ET; Newkirk SE; Thévenin D; Pires MM
Front Immunol; 2024; 15():1337973. PubMed ID: 38665920
[TBL] [Abstract][Full Text] [Related]
14. Modified peptides in anti-cancer vaccines: are we eventually improving anti-tumour immunity?
Iero M; Filipazzi P; Castelli C; Belli F; Valdagni R; Parmiani G; Patuzzo R; Santinami M; Rivoltini L
Cancer Immunol Immunother; 2009 Jul; 58(7):1159-67. PubMed ID: 18998128
[TBL] [Abstract][Full Text] [Related]
15. Inflammation-Induced Abnormal Expression of Self-molecules on Epithelial Cells: Targets for Tumor Immunoprevention.
Jacqueline C; Lee A; Frey N; Minden JS; Finn OJ
Cancer Immunol Res; 2020 Aug; 8(8):1027-1038. PubMed ID: 32467324
[TBL] [Abstract][Full Text] [Related]
16. A novel synthetic bipartite carrier protein for developing glycotope-based vaccines.
Chiang HL; Lin CY; Jan FD; Lin YS; Hsu CT; Whang-Peng J; Liu LF; Nieh S; Lin CC; Hwang J
Vaccine; 2012 Dec; 30(52):7573-81. PubMed ID: 23099332
[TBL] [Abstract][Full Text] [Related]
17. Cationic micelle delivery of a multi-epitope vaccine candidate derived from tumor-associated antigens, causing regression in established CT26 colorectal tumors in mice.
Sabzehei F; Taromchi AH; Ramazani A; Nedaei K; Feizi A; Arsang-Jang S; Danafar H
J Biomed Mater Res A; 2024 May; 112(5):733-742. PubMed ID: 38088136
[TBL] [Abstract][Full Text] [Related]
18. A serologically identified tumor antigen encoded by a homeobox gene promotes growth of ovarian epithelial cells.
Naora H; Yang YQ; Montz FJ; Seidman JD; Kurman RJ; Roden RB
Proc Natl Acad Sci U S A; 2001 Mar; 98(7):4060-5. PubMed ID: 11274429
[TBL] [Abstract][Full Text] [Related]
19. Inflammation and immunity in ovarian cancer.
Salas-Benito D; Vercher E; Conde E; Glez-Vaz J; Tamayo I; Hervas-Stubbs S
EJC Suppl; 2020 Aug; 15():56-66. PubMed ID: 33240443
[TBL] [Abstract][Full Text] [Related]
20. Th17-inducing autologous dendritic cell vaccination promotes antigen-specific cellular and humoral immunity in ovarian cancer patients.
Block MS; Dietz AB; Gustafson MP; Kalli KR; Erskine CL; Youssef B; Vijay GV; Allred JB; Pavelko KD; Strausbauch MA; Lin Y; Grudem ME; Jatoi A; Klampe CM; Wahner-Hendrickson AE; Weroha SJ; Glaser GE; Kumar A; Langstraat CL; Solseth ML; Deeds MC; Knutson KL; Cannon MJ
Nat Commun; 2020 Oct; 11(1):5173. PubMed ID: 33057068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
